市場調査レポート
商品コード
1373493

ヒト免疫不全ウイルス(HIV)迅速検査キットの世界市場 2024-2028

Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2024-2028

出版日: | 発行: TechNavio | ページ情報: 英文 164 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.55円
ヒト免疫不全ウイルス(HIV)迅速検査キットの世界市場 2024-2028
出版日: 2023年10月25日
発行: TechNavio
ページ情報: 英文 164 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

ヒト免疫不全ウイルス(HIV)迅速検査キット市場2024-2028

ヒト免疫不全ウイルス(HIV)迅速検査キット市場は2023-2028年に2億9,496万米ドル、予測期間中のCAGRは6.52%で成長すると予測されています。この調査レポートは、ヒト免疫不全ウイルス(HIV)迅速検査キット市場の全体分析、市場規模、予測、動向、成長促進要因、課題を掲載し、約25のベンダーを網羅しています。

市場範囲
基準年 2023
終了年 2028
予測期間 2024-2028
成長モメンタム 加速
前年比2024年 5.45%
CAGR 6.52%
増分額 2億9,496万米ドル

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、HIV検査の啓発プログラムの増加、HIVのポイントオブケア検査に対する需要の高まり、HIVの高い有病率によって牽引されています。

本調査では、今後数年間のヒト免疫不全ウイルス(HIV)迅速検査キット市場の成長を促進する主な理由の1つとして、HIVの婚前スクリーニングを増加させる取り組みを挙げています。また、研究者による臨床研究の増加やメーカーによるプロモーション活動、ベンダーによる幅広いHIV迅速検査キットの提供は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2023
  • 市場の見通し 2023-2028

第4章 市場規模実績

  • ヒト免疫不全ウイルス(HIV)迅速検査キットの世界市場 2018-2022
  • エンドユーザーセグメント分析 2018-2022
  • タイプセグメント分析 2018-2022
  • 地域別セグメント分析 2018-2022
  • 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:エンドユーザー別

  • 市場セグメント
  • 比較:エンドユーザー別
  • 診断センター:市場規模と予測 2023-2028
  • 病院と診療所:市場規模と予測 2023-2028
  • 市場機会:エンドユーザー別

第7章 市場セグメンテーション:タイプ別

  • 市場セグメント
  • 比較:タイプ別
  • HIV迅速免疫測定検査:市場規模と予測 2023-2028
  • HIV迅速分子診断検査:市場規模と予測 2023-2028
  • 市場機会:タイプ別

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2023-2028
  • 欧州:市場規模と予測 2023-2028
  • アジア:市場規模と予測 2023-2028
  • 世界のその他の地域:市場規模と予測 2023-2028
  • 米国:市場規模と予測 2023-2028
  • 英国:市場規模と予測 2023-2028
  • 中国:市場規模と予測 2023-2028
  • ドイツ:市場規模と予測 2023-2028
  • カナダ:市場規模と予測 2023-2028
  • 市場機会:地域別

第10章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第11章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • AccuQuik Test Kits
  • Becton Dickinson and Co.
  • bioLytical Laboratories Inc.
  • bioMerieux SA
  • Chembio Diagnostics Inc.
  • Danaher Corp.
  • DrSafeHands
  • F. Hoffmann La Roche Ltd.
  • Fujirebio Holdings Inc.
  • Healgen Scientific, LLC
  • Hologic Inc.
  • J. Mitra and Co. Pvt. Ltd.
  • MP Biomedicals Inc.
  • OraSure Technologies Inc.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market by Geography
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Historic Market Size - Data Table on global human immunodeficiency virus (hiv) rapid test kits market 2018 - 2022 ($ million)
  • Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on End-user - Market share 2023-2028 (%)
  • Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by End-user
  • Exhibits33: Data Table on Comparison by End-user
  • Exhibits34: Chart on Diagnostic centers - Market size and forecast 2023-2028 ($ million)
  • Exhibits35: Data Table on Diagnostic centers - Market size and forecast 2023-2028 ($ million)
  • Exhibits36: Chart on Diagnostic centers - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on Diagnostic centers - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
  • Exhibits39: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
  • Exhibits40: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Market opportunity by End-user ($ million)
  • Exhibits43: Data Table on Market opportunity by End-user ($ million)
  • Exhibits44: Chart on Type - Market share 2023-2028 (%)
  • Exhibits45: Data Table on Type - Market share 2023-2028 (%)
  • Exhibits46: Chart on Comparison by Type
  • Exhibits47: Data Table on Comparison by Type
  • Exhibits48: Chart on HIV rapid immunoassay test - Market size and forecast 2023-2028 ($ million)
  • Exhibits49: Data Table on HIV rapid immunoassay test - Market size and forecast 2023-2028 ($ million)
  • Exhibits50: Chart on HIV rapid immunoassay test - Year-over-year growth 2023-2028 (%)
  • Exhibits51: Data Table on HIV rapid immunoassay test - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Chart on HIV rapid molecular diagnostic test - Market size and forecast 2023-2028 ($ million)
  • Exhibits53: Data Table on HIV rapid molecular diagnostic test - Market size and forecast 2023-2028 ($ million)
  • Exhibits54: Chart on HIV rapid molecular diagnostic test - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on HIV rapid molecular diagnostic test - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Market opportunity by Type ($ million)
  • Exhibits57: Data Table on Market opportunity by Type ($ million)
  • Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits59: Chart on Market share by geography 2023-2028 (%)
  • Exhibits60: Data Table on Market share by geography 2023-2028 (%)
  • Exhibits61: Chart on Geographic comparison
  • Exhibits62: Data Table on Geographic comparison
  • Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits83: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits84: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits85: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits86: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits87: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits88: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits89: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits90: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits97: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits99: Market opportunity by geography ($ million)
  • Exhibits100: Data Tables on Market opportunity by geography ($ million)
  • Exhibits101: Impact of drivers and challenges in 2023 and 2028
  • Exhibits102: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits103: Overview on factors of disruption
  • Exhibits104: Impact of key risks on business
  • Exhibits105: Vendors covered
  • Exhibits106: Matrix on vendor position and classification
  • Exhibits107: Abbott Laboratories - Overview
  • Exhibits108: Abbott Laboratories - Business segments
  • Exhibits109: Abbott Laboratories - Key news
  • Exhibits110: Abbott Laboratories - Key offerings
  • Exhibits111: Abbott Laboratories - Segment focus
  • Exhibits112: AccuQuik Test Kits - Overview
  • Exhibits113: AccuQuik Test Kits - Product / Service
  • Exhibits114: AccuQuik Test Kits - Key offerings
  • Exhibits115: Becton Dickinson and Co. - Overview
  • Exhibits116: Becton Dickinson and Co. - Business segments
  • Exhibits117: Becton Dickinson and Co. - Key news
  • Exhibits118: Becton Dickinson and Co. - Key offerings
  • Exhibits119: Becton Dickinson and Co. - Segment focus
  • Exhibits120: bioLytical Laboratories Inc. - Overview
  • Exhibits121: bioLytical Laboratories Inc. - Product / Service
  • Exhibits122: bioLytical Laboratories Inc. - Key offerings
  • Exhibits123: bioMerieux SA - Overview
  • Exhibits124: bioMerieux SA - Product / Service
  • Exhibits125: bioMerieux SA - Key news
  • Exhibits126: bioMerieux SA - Key offerings
  • Exhibits127: Chembio Diagnostics Inc. - Overview
  • Exhibits128: Chembio Diagnostics Inc. - Product / Service
  • Exhibits129: Chembio Diagnostics Inc. - Key offerings
  • Exhibits130: Danaher Corp. - Overview
  • Exhibits131: Danaher Corp. - Business segments
  • Exhibits132: Danaher Corp. - Key news
  • Exhibits133: Danaher Corp. - Key offerings
  • Exhibits134: Danaher Corp. - Segment focus
  • Exhibits135: DrSafeHands - Overview
  • Exhibits136: DrSafeHands - Product / Service
  • Exhibits137: DrSafeHands - Key offerings
  • Exhibits138: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits139: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits140: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits141: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits142: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits143: Fujirebio Holdings Inc. - Overview
  • Exhibits144: Fujirebio Holdings Inc. - Product / Service
  • Exhibits145: Fujirebio Holdings Inc. - Key offerings
  • Exhibits146: Healgen Scientific, LLC - Overview
  • Exhibits147: Healgen Scientific, LLC - Product / Service
  • Exhibits148: Healgen Scientific, LLC - Key offerings
  • Exhibits149: Hologic Inc. - Overview
  • Exhibits150: Hologic Inc. - Business segments
  • Exhibits151: Hologic Inc. - Key news
  • Exhibits152: Hologic Inc. - Key offerings
  • Exhibits153: Hologic Inc. - Segment focus
  • Exhibits154: J. Mitra and Co. Pvt. Ltd. - Overview
  • Exhibits155: J. Mitra and Co. Pvt. Ltd. - Product / Service
  • Exhibits156: J. Mitra and Co. Pvt. Ltd. - Key offerings
  • Exhibits157: MP Biomedicals Inc. - Overview
  • Exhibits158: MP Biomedicals Inc. - Key offerings
  • Exhibits159: OraSure Technologies Inc. - Overview
  • Exhibits160: OraSure Technologies Inc. - Business segments
  • Exhibits161: OraSure Technologies Inc. - Key offerings
  • Exhibits162: OraSure Technologies Inc. - Segment focus
  • Exhibits163: Inclusions checklist
  • Exhibits164: Exclusions checklist
  • Exhibits165: Currency conversion rates for US$
  • Exhibits166: Research methodology
  • Exhibits167: Validation techniques employed for market sizing
  • Exhibits168: Information sources
  • Exhibits169: List of abbreviations
目次
Product Code: IRTNTR45322

Abstract

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2024-2028

The human immunodeficiency virus (HIV) rapid test kits market is forecasted to grow by USD 294.96 mn during 2023-2028, accelerating at a CAGR of 6.52% during the forecast period. The report on the human immunodeficiency virus (HIV) rapid test kits market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

Market Scope
Base Year2023
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20245.45%
CAGR6.52%
Incremental Value$294.96mn

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a rise in awareness programs for HIV testing, growing demand for point-of-care testing for HIV, and a high prevalence of HIV.

Technavio's human immunodeficiency virus (HIV) rapid test kits market is segmented as below:

By End-user

  • Diagnostic centers
  • Hospitals
  • clinics

By Type

  • HIV rapid immunoassay test
  • HIV rapid molecular diagnostic test

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the efforts to increase pre-marital screenings for HIV as one of the prime reasons driving the human immunodeficiency virus (HIV) rapid test kits market growth during the next few years. Also, increasing clinical studies by researchers and promotional activities by manufacturers, and the availability of a broad range of HIV rapid test kits by vendors will lead to sizable demand in the market.

The report on the human immunodeficiency virus (HIV) rapid test kits market covers the following areas:

  • Human immunodeficiency virus (HIV) rapid test kits market sizing
  • Human immunodeficiency virus (HIV) rapid test kits market forecast
  • Human immunodeficiency virus (HIV) rapid test kits market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human immunodeficiency virus (HIV) rapid test kits market vendors that include Abbott Laboratories, AccuQuik Test Kits, Amkay Products Pvt. Ltd., Becton Dickinson and Co., Bhat Bio Tech India Pvt Ltd., bioLytical Laboratories Inc., bioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., DrSafeHands, F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., Healgen Scientific, LLC, Hologic Inc., J. Mitra and Co. Pvt. Ltd., MP Biomedicals Inc., Oragenics Inc., OraSure Technologies Inc., Pathkits Heathcare Pvt. Ltd., and SHINE SA. Also, the human immunodeficiency virus (HIV) rapid test kits market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market by Geography
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global human immunodeficiency virus (HIV) rapid test kits market 2018 - 2022
  • Exhibit 18: Historic Market Size - Data Table on global human immunodeficiency virus (hiv) rapid test kits market 2018 - 2022 ($ million)
  • 4.2 End-user Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • 4.3 Type Segment Analysis 2018 - 2022
  • Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • 4.4 Geography Segment Analysis 2018 - 2022
  • Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country Segment Analysis 2018 - 2022
  • Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

  • 6.1 Market segments
  • Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
  • Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
  • 6.2 Comparison by End-user
  • Exhibit 32: Chart on Comparison by End-user
  • Exhibit 33: Data Table on Comparison by End-user
  • 6.3 Diagnostic centers - Market size and forecast 2023-2028
  • Exhibit 34: Chart on Diagnostic centers - Market size and forecast 2023-2028 ($ million)
  • Exhibit 35: Data Table on Diagnostic centers - Market size and forecast 2023-2028 ($ million)
  • Exhibit 36: Chart on Diagnostic centers - Year-over-year growth 2023-2028 (%)
  • Exhibit 37: Data Table on Diagnostic centers - Year-over-year growth 2023-2028 (%)
  • 6.4 Hospitals and clinics - Market size and forecast 2023-2028
  • Exhibit 38: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
  • Exhibit 39: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
  • Exhibit 40: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • Exhibit 41: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • 6.5 Market opportunity by End-user
  • Exhibit 42: Market opportunity by End-user ($ million)
  • Exhibit 43: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Type

  • 7.1 Market segments
  • Exhibit 44: Chart on Type - Market share 2023-2028 (%)
  • Exhibit 45: Data Table on Type - Market share 2023-2028 (%)
  • 7.2 Comparison by Type
  • Exhibit 46: Chart on Comparison by Type
  • Exhibit 47: Data Table on Comparison by Type
  • 7.3 HIV rapid immunoassay test - Market size and forecast 2023-2028
  • Exhibit 48: Chart on HIV rapid immunoassay test - Market size and forecast 2023-2028 ($ million)
  • Exhibit 49: Data Table on HIV rapid immunoassay test - Market size and forecast 2023-2028 ($ million)
  • Exhibit 50: Chart on HIV rapid immunoassay test - Year-over-year growth 2023-2028 (%)
  • Exhibit 51: Data Table on HIV rapid immunoassay test - Year-over-year growth 2023-2028 (%)
  • 7.4 HIV rapid molecular diagnostic test - Market size and forecast 2023-2028
  • Exhibit 52: Chart on HIV rapid molecular diagnostic test - Market size and forecast 2023-2028 ($ million)
  • Exhibit 53: Data Table on HIV rapid molecular diagnostic test - Market size and forecast 2023-2028 ($ million)
  • Exhibit 54: Chart on HIV rapid molecular diagnostic test - Year-over-year growth 2023-2028 (%)
  • Exhibit 55: Data Table on HIV rapid molecular diagnostic test - Year-over-year growth 2023-2028 (%)
  • 7.5 Market opportunity by Type
  • Exhibit 56: Market opportunity by Type ($ million)
  • Exhibit 57: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 59: Chart on Market share by geography 2023-2028 (%)
  • Exhibit 60: Data Table on Market share by geography 2023-2028 (%)
  • 9.2 Geographic comparison
  • Exhibit 61: Chart on Geographic comparison
  • Exhibit 62: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
  • Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
  • Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
  • Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 UK - Market size and forecast 2023-2028
  • Exhibit 83: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibit 84: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibit 85: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibit 86: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.9 China - Market size and forecast 2023-2028
  • Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.10 Germany - Market size and forecast 2023-2028
  • Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.11 Canada - Market size and forecast 2023-2028
  • Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity by geography
  • Exhibit 99: Market opportunity by geography ($ million)
  • Exhibit 100: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 101: Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 103: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 104: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 105: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 106: Matrix on vendor position and classification
  • 12.3 Abbott Laboratories
  • Exhibit 107: Abbott Laboratories - Overview
  • Exhibit 108: Abbott Laboratories - Business segments
  • Exhibit 109: Abbott Laboratories - Key news
  • Exhibit 110: Abbott Laboratories - Key offerings
  • Exhibit 111: Abbott Laboratories - Segment focus
  • 12.4 AccuQuik Test Kits
  • Exhibit 112: AccuQuik Test Kits - Overview
  • Exhibit 113: AccuQuik Test Kits - Product / Service
  • Exhibit 114: AccuQuik Test Kits - Key offerings
  • 12.5 Becton Dickinson and Co.
  • Exhibit 115: Becton Dickinson and Co. - Overview
  • Exhibit 116: Becton Dickinson and Co. - Business segments
  • Exhibit 117: Becton Dickinson and Co. - Key news
  • Exhibit 118: Becton Dickinson and Co. - Key offerings
  • Exhibit 119: Becton Dickinson and Co. - Segment focus
  • 12.6 bioLytical Laboratories Inc.
  • Exhibit 120: bioLytical Laboratories Inc. - Overview
  • Exhibit 121: bioLytical Laboratories Inc. - Product / Service
  • Exhibit 122: bioLytical Laboratories Inc. - Key offerings
  • 12.7 bioMerieux SA
  • Exhibit 123: bioMerieux SA - Overview
  • Exhibit 124: bioMerieux SA - Product / Service
  • Exhibit 125: bioMerieux SA - Key news
  • Exhibit 126: bioMerieux SA - Key offerings
  • 12.8 Chembio Diagnostics Inc.
  • Exhibit 127: Chembio Diagnostics Inc. - Overview
  • Exhibit 128: Chembio Diagnostics Inc. - Product / Service
  • Exhibit 129: Chembio Diagnostics Inc. - Key offerings
  • 12.9 Danaher Corp.
  • Exhibit 130: Danaher Corp. - Overview
  • Exhibit 131: Danaher Corp. - Business segments
  • Exhibit 132: Danaher Corp. - Key news
  • Exhibit 133: Danaher Corp. - Key offerings
  • Exhibit 134: Danaher Corp. - Segment focus
  • 12.10 DrSafeHands
  • Exhibit 135: DrSafeHands - Overview
  • Exhibit 136: DrSafeHands - Product / Service
  • Exhibit 137: DrSafeHands - Key offerings
  • 12.11 F. Hoffmann La Roche Ltd.
  • Exhibit 138: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 139: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 140: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 141: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 142: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.12 Fujirebio Holdings Inc.
  • Exhibit 143: Fujirebio Holdings Inc. - Overview
  • Exhibit 144: Fujirebio Holdings Inc. - Product / Service
  • Exhibit 145: Fujirebio Holdings Inc. - Key offerings
  • 12.13 Healgen Scientific, LLC
  • Exhibit 146: Healgen Scientific, LLC - Overview
  • Exhibit 147: Healgen Scientific, LLC - Product / Service
  • Exhibit 148: Healgen Scientific, LLC - Key offerings
  • 12.14 Hologic Inc.
  • Exhibit 149: Hologic Inc. - Overview
  • Exhibit 150: Hologic Inc. - Business segments
  • Exhibit 151: Hologic Inc. - Key news
  • Exhibit 152: Hologic Inc. - Key offerings
  • Exhibit 153: Hologic Inc. - Segment focus
  • 12.15 J. Mitra and Co. Pvt. Ltd.
  • Exhibit 154: J. Mitra and Co. Pvt. Ltd. - Overview
  • Exhibit 155: J. Mitra and Co. Pvt. Ltd. - Product / Service
  • Exhibit 156: J. Mitra and Co. Pvt. Ltd. - Key offerings
  • 12.16 MP Biomedicals Inc.
  • Exhibit 157: MP Biomedicals Inc. - Overview
  • Exhibit 158: MP Biomedicals Inc. - Key offerings
  • 12.17 OraSure Technologies Inc.
  • Exhibit 159: OraSure Technologies Inc. - Overview
  • Exhibit 160: OraSure Technologies Inc. - Business segments
  • Exhibit 161: OraSure Technologies Inc. - Key offerings
  • Exhibit 162: OraSure Technologies Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 163: Inclusions checklist
  • Exhibit 164: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 165: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 166: Research methodology
  • Exhibit 167: Validation techniques employed for market sizing
  • Exhibit 168: Information sources
  • 13.5 List of abbreviations
  • Exhibit 169: List of abbreviations